Nureca Limited , a healthcare and wellness products company, has published its post-buyback public announcement following the Board's approval of a ₹19.14 crore share buyback program, completing key regulatory requirements under SEBI Buyback Regulations.

Buyback Program Details

The Board of Directors approved the buyback program on November 28, 2025, with the company appointing Mefcom Capital Markets Limited as the manager to oversee the buyback process. The program targets up to 5,80,000 equity shares at a maximum price of ₹330.00 per share.

Regulatory Compliance and Publication

Pursuant to Regulation 24(vi) of the SEBI Buyback Regulations, Nureca Limited published its post-buyback public announcement dated December 31, 2025, in multiple newspapers on January 1, 2026. The announcement ensures compliance with regulatory disclosure requirements.

Contact Information and Next Steps

The company has designated Ms. Nishu Kansal, Company Secretary & Compliance Officer, as the authorized contact person for buyback-related queries. Shareholders can reach her at +91 22 4961 6173 or nishu.kansal@nureca.com for further information or clarification regarding the buyback process.

The buyback will be conducted through the stock exchange mechanism on a proportionate basis for eligible shareholders as of the record date. This approach ensures fair participation opportunities for all qualifying shareholders while maintaining transparency in the process.

Nureca Limited has announced the relocation of its registered office within Mumbai, marking a significant administrative development for the healthcare and consumer products company. The shift became effective on December 10, 2025, as communicated to both major stock exchanges.

Office Relocation Details

The company has moved its registered office from the eastern suburbs to the western part of Mumbai. This transition represents a strategic administrative decision that may enhance operational efficiency and accessibility.

Regulatory Compliance

Nureca Limited has fulfilled its regulatory obligations by promptly informing the stock exchanges about this corporate action. The notification was filed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates listed companies to disclose material events and corporate developments.

The communication was signed by Nishu Kansal, Company Secretary and Compliance Officer (Membership No. A33372), ensuring proper authorization and compliance with corporate governance standards. The digital signature was applied on December 10, 2025, at 17:02:23.

Corporate Structure

While the registered office has been relocated, Nureca Limited maintains its correspondence office at SCO 6-7-8, 1st Floor, Madhya Marg, Sector 9-D, Chandigarh-160009. The company continues to operate under CIN L24304MH2016PLC320868 and can be reached at phone number 91-172-5292900.

Stock Exchange Information

The company has requested both BSE Limited and National Stock Exchange of India Limited to take note of this information and arrange for its proper dissemination to market participants.

This administrative change reflects the company's ongoing operational adjustments and commitment to maintaining transparent communication with regulatory authorities and stakeholders.